跳至主要内容
临床试验/NCT06529965
NCT06529965招募中不适用

Evaluating a Digital Intervention for Alleviating Diabetes-specific Emotional Distress in Adults Living With Type 2 Diabetes Mellitus: Randomized Controlled Trial

Gaia AG2 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2024年10月9日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
Gaia AG
入组人数
250
试验地点
2
主要终点
Diabetes-specific emotional distress

研究概览

简要总结

This randomized controlled trial (RCT) with 250 patients suffering from type 2 diabetes mellitus (T2DM) aims to investigate the effectiveness of the self-guided digital therapeutic covivio. Inclusion criteria are: male, female or non-binary; age ≥ 18 years; confirmed diagnosis of T2DM; elevated levels of diabetes-specific emotional distress (Problem Areas in Diabetes [PAID]-20 score ≥ 33); consent to participate; sufficient German language skills. Exclusion criteria are: a diagnosis of type 1 diabetes mellitus (T1DM); current use of continuous glucose monitoring (CGM) as part of one's diabetes treatment; changes or planned changes in medication within 4 weeks before the baseline visit or in the subsequent 6 months; a bariatric operation within 4 weeks before the baseline visit or such an operation planned in the subsequent 6 months; changes or planned changes in psychotherapeutic treatment within 4 weeks before the baseline visit or in the subsequent 6 months. In addition, participants will be excluded from the study if they did not wear the CGM sensor for at least 6 of 7 days at baseline (before randomization), providing a minimum of 96 hours of glucose values including at least 24 hours overnight.

Patients will be randomized and allocated in a 1:1 ratio to either an intervention group, in which they will receive access to covivio in addition to treatment as usual (TAU, n = 125), or to a control group, in which they will receive only TAU (n = 125).

Co-primary endpoints of this trial will be the between-groups difference in the PAID-20 total score in the intervention and control group at six months, adjusted for the PAID-20 baseline score as well as the glucose management indicator (estimated HbA1c) assessed using continuous glucose monitoring devices (for a period of 7 days) at six months, adjusted for the baseline score.

Secondary endpoints will be diabetes self-management skills, body mass index (BMI), and quality of life.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • male, female or non-binary
  • age ≥ 18 years
  • diagnosis of T2DM secured via submission of a medical certificate attesting to the presence of at least one of the following ICD-10-GM diagnoses of T2DM: E11.20, E11.30, E11.40, E11.50, E11.60, E11.72, E11.74, E11.80, E11.90
  • elevated levels of diabetes-specific emotional distress: cut-off ≥ 33 on the PAID-20
  • access to CGM-compatible smartphone
  • consent to participate
  • sufficient knowledge of the German language

排除标准

  • diagnosis of type 1 diabetes mellitus (T1DM)
  • change in medication (type, frequency of use or dosage) within 4 weeks before the baseline visit or planned within the subsequent 6 months
  • recent or planned bariatric operation within 4 weeks before the baseline visit or within the subsequent 6 months
  • change in psychotherapeutic treatment within 4 weeks before the baseline visit or planned within the subsequent 6 months
  • current use of continuous glucose monitoring (CGM) as part of one's diabetes treatment
  • experiencing problems with the CGM sensor or insufficient CGM data quality at baseline (T0) (i.e., wearing the CGM sensor on less than 6 of 7 days, providing less than a minimum of 96 hours of glucose values, providing less than 24 hours overnight CGM data)

结局指标

主要结局

Diabetes-specific emotional distress

时间窗: 6 months

Assessed with the Problem Areas in Diabetes Questionnaire (PAID-20). Total score ranging from 0-100; higher scores indicate higher diabetes-specific emotional distress (worse outcome).

Glucose management indicator

时间窗: 6 months

The glucose management indicator (GMI) is an estimation of HbA1c from CGM. It is calculated as follows: GMI (%) = 3.31 + 0.02392 x \[mean glucose in mg/dL\].

次要结局

  • Diabetes-specific emotional distress(3 months)
  • Diet self-management skills(3 months; 6 months)
  • Exercise self-management skills(3 months; 6 months)
  • Body mass index (BMI)(3 months; 6 months)
  • Health-related quality of life(3 months; 6 months)

研究者

发起方
Gaia AG
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验